Because COVID‐19 uses both ACE2 and the accessory protease TMPRSS2 to gain access to human cells, we confirmed co‐expression of ACE2 and TMPRSS2 in human cardiomyocytes (Figure1D). This evidence concerns the gene ACE2 and COVID-19.